References

cardiovascular

Кардиоваскулярная терапия и профилактика

Cardiovascular Therapy and Prevention

1728-88002619-0125

«SILICEA-POLIGRAF» LLC

10.15829/1728-8800-2016-1-77-83

cardiovascular-332

Research Article

ОБЗОРЫ

REVIEWS

Современная стратегия, тактика ведения и прогноз пациентов со стабильной ишемической болезнью сердца

Modern strategy, management and outcomes for stable ischemic heart disease patients

Лупанов

В. П.

Lupanov

V. P.

д.м.н., профессор, в.н.с. отдела проблем атеросклероза

Lupanovvp@mail.ru

Институт клинической кардиологии им. А. Л. Мясникова ФГБУ «Российский кардиологический научно-производственный комплекс» Минздрава России. МоскваРоссияA. L. Myasnikov Clinical Cardiology Institute, Russian Cardiological Research-and-Production Complex of the Ministry of Health. Moscow, RussiaRussian Federation

2016

20022016

1517783

2016

Лупанов В.П.

Lupanov V.P.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://cardiovascular.elpub.ru/jour/article/view/332

Анализируется современная тактика ведения пациентов со стабильной ишемической болезнью сердца, позволяющая врачам-кардиологам правильно оценить риск и пользу диагностических исследований, выбрать медикаментозный или хирургический метод лечения и оценить прогноз больных. В обзоре даются рекомендации, помогающие врачам в принятии решений по лечению пациентов с ишемической болезнью сердца в повседневной практике.

The analysis provided, of modern tactics for stable ischemic heart disease patients that makes it possible for practitioners to estimate adequately risk and benefits of diagnostic studies, to select medical or surgical treatment method and to assess outcomes. The review provides with recommendations helping physicians with decision making on patients treatment with ischemic heart disease in everyday practice.

ишемическая болезнь сердцастенозирующий коронарный атеросклерозстенокардиястратегия лечениятактика ведения больныхпроспективное наблюдениепрогноз

ischemic heart diseasestenotic coronary atherosclerosisanginatreatment strategymanagement tacticsprospective observationprognosis

References1

Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2014; sept. 10, doi:10.1093/eurheartj/ehu 278

International Statistical Classification of Diseases (ICD-10) and Related Health Problems. Ten revisions, World Health Organization, Geneva, 1992. Russian (Международная статистическая классификация болезней и проблем, связанных со здоровьем (MKБ-10). Десятый пересмотр. Всемирная организация здравоохранения (ВОЗ), Женева, 1992).

Fihn SD, Cardin JM, Abrams J, et al. ACCF/AHA/ACP/AATS/PCNA/SCAI/SNS Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease. JACC 2012; 60(24): e44-164.

Rational pharmacotherapy for cardiovascular diseases. A guidebook for medical practitioners. 2nd-edition, revised. Editor: Chazov E.I., Karpov U.A. Moscow, Literra Publishers, 2014. 1056 р. Russian (Рациональная фармакотерапия сердечно-сосудистых заболеваний. Под общ. ред. Чазова Е.И., Карпова Ю.А. 2 изд. испр. и доп. М.: Литтерра 2014. 1056 с).

Karpov YuA, Kukharchuk VV, Lyakishev AA, et al. Diagnosis and treatment of chronic ischemic heart disease. Clinical guidelines. Authors (working group-preparing guidelines): Kardiologicheskij Vestnik 2015; 3: 3-33. Russian (Карпов Ю.А., Кухарчук В.В., Лякишев А.А. и др. Диагностика и лечение хронической ишемической болезни сердца. Авторы (рабочая группа по подготовке теста рекомендаций): Кардиологический Вестник 2015; 3: 3-33).

Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003.

Bauters C, Deneve M, Tricot O, et al. Prognosis of patients with stable coronary artery disease (from the CORONOR Study). Am J Cardiol 2014; 113: 1142-5.

Guidelines on the management of stable angina pectoris – executive summary. The Task Force on the Management of stable angina pectoris of the European Society of Cardiology (Fox K. et al.). Eur Heart J 2006; 27: 1341-81.

Lupanov VP. Silent myocardial ischemia: medical therapy or revascularisation, prognosis (review). Consilium Medicum 2012; 14(10): 36-44. Russian (Лупанов В.П. Безболевая ишемия миокарда: диагностика, медикаментозное и хирургическое лечение, прогноз (обзор). Consilium Medicum 2012; 14(10): 36-44).

Lupanov VP, Chotchaev KhKh, Evstifeeva SE, et al. Clinical course of disease and prognosis in patients with ischemic heart disease with stable angina pectoris, caused by stenosing coronary atherosclerosis (data from a 20-year study). Ter Arkhiv 2002; 74(9): 13-20. Russian (Лупанов В.П., Чотчаев Х.Х., Евстифеева С.Е. и др. Клиническое течение заболевания и прогноз больных ишемической болезнью сердца со стабильной стенокардией, обусловленной стенозирующим коронарным атеросклерозом (данные 20-летнего наблюдения). Тер архив 2002; 74(9): 13-20).

Boytsov SA, Karpov YuA, Kukharchuk VV, et al. Identification of patients at high cardiovascular risk: problem and possible solutions (Part I). Atheroscleros and dyslipidemias 2010; 1: 8-14. Russian (Бойцов С.А., Карпов Ю.А., Кухарчук В.В. и др. Проблемы выявления лиц с высоким сердечно-сосудистым риском и возможные пути их решения (Часть I). Атеросклероз и дислипидемии 2010; 1(1): 8-14).

National recommendations about diagnostics and treatment of stable stenocardia. Cardiovascular Therapy and Prevention 2008; 7(6), Suppl. 4. Russian (Национальные рекомендации по диагностике и лечению стабильной стенокардии. Кардиоваскулярная терапия и профилактика 2008;7(6), Приложение 4).

Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatiens with atherothrombosis. JAMA 2007; 297: 1197-206.

Akchurin RS, Shiryaev AA, Rudenko BA, et al. The angiographic patterns of the invasive intervention. Kardiologicheskij Vestnik 2011; VI (XVIII); 2: 37-45. Russian (Акчурин Р.С., Ширяев А.А., Руденко Б.А. и др. Ангиографические характеристики инвазивных вмешательств. Кардиологический Вестник 2011: VI (XVIII); 2: 37-45).

Savchenko AP, Rudenko BA, Cherkavskaya OV. Endovascular technologies in the treatment of coronary heart disease: accumulated experience and perspectives for development. Kardiologicheskij Vestnik 2010; 10: 49-55). Russian (Савченко А.П., Руденко Б.А., Черкавская О.В. Эндоваскулярные технологии и лечение ишемической болезни сердца: накопленный опыт и перспективы развития. Кардиологический Вестник 2010; 10: 49-55).

Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel dissease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-7.

Kappetein PA, Feldman TE, Mack ME. Comparison of coronary bypass surgery with drug-elutimg stenting for the treatment of left main and/or three-vessel disease: 3-year follow up of the SYNTAX trial. Eur Heart J 2011; 32: 2125-34.

Yan TD, Padang R, Poh C, et al. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg 2011; 141: 1134-44.

Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-5.

Lupanov VP, Ageev FT. A strategy for management and treatment of patients with stable ischemic heart disease in outpatient and inpatient conditions. Heart: the magazine for the practing doctors 2004; 3(2): 56-66. Russian (Стратегия ведения и лечения больных стабильной ишемической болезнью сердца в стационаре и в амбулаторных условиях. Сердце: журнал для практикующих врачей 2004; 3(2): 56-66).

Plisterer M, Buser P, Osswald S, et al. Outcome of Elderly Patients with Chronic Symptomatic Coronary Artery Disease with an Invasive vs Optimized Medical treatment Strategy. One-Year Results on the Randomized TIME Trial) / The Trial of Invasive versus Medical therapy in Elderly patients. JAMA 2003; 289(9): 1117-23.

Нueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-9.

Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007; 297: 1985-91.

Boden WE, O΄Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-16.

Frye RL, August P, Brooks MM. A randomamized trial of therapies for 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-15.

Nishigaki K, Yamazaki T, Kitabatake A, et al. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv 2008; 1: 469-79.

de Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Eng J Med 2012; 367: 991-1001.

Нarris PJ, Harrell FEJr, Lee KE, et al. Survival in medically treated coronary artery disease. Circulation 1979; 60: 1259-69.

Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a servey on the lifestyle, risk factors and use cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121-37.

Cohen DJ, van Hout B, Serruys PW, et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med 2011; 64: 1016-26.

Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74.

Califf RM, Mark DB, Harrell FE Jr, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. JACC 1988; 11: 20-6.

Henderson RF, OFlynn N. Management of stable angina: summary of NICE guidance. Heart 2012; 98: 500-7.

Lupanov VP. Diagnostic and prognostic role of the modern instrumental methоds for cardiovascular examination in patiеnts with coronary heart disease). Cardiovascular Therapy and Prevention 2011; 10(5): 106-15). Russian (Лупанов В.П. Современные функциональные методы исследования сердечно-сосудистой системы в диагностике, оценке тяжести и прогнозе больных ишемической болезнью сердца. Кардиоваскулярная терапия и профилактика 2011; 10(5): 106-15).

Gossl M, Faxon DP, Bell VR, et al. Complete versus incomplete revascularization with cоronary artery graft or percutaneous intervention in stable coronary artery disease. Circ Cardiovasc Interv 2012; 5: 597-604.

Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. E Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 2007; 297: 1775-83.

Lupanov VP. New antianginal medicament ranolazin in ischemic heart disease patients (scientific review). Terapevt 2015; 1: 67-77. Russian (Лупанов В.П. Новый антиангинальный препарат ранолазин у больных ишемической болезнью сердца (научный обзор). Терапевт 2015; 1: 67-77).

Weisz G, Genereux P, Iniguez A, et al. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-conrolled trial. Lancet 2015; Published online October 13: 1-9. http://dx.doi.org/10./1016/S0140-6736(15)00459-6.

The authors declare that there are no conflicts of interest present.